Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bicara Therapeutics Inc. | 0 | 2,204,650 | +2,204,650 | $0 | $56.15M | 35.09% | +$56.15M |
| Nuvation Bio Inc.CL A(NUVB) | 13,275,884 | 13,072,340 | -203,544 | $38.77M | $29.94M | 18.71% | -$8.83M |
| Replimune Group, Inc.(REPL) | 2,461,319 | 2,461,319 | 0 | $22.15M | $26.98M | 16.86% | +$4.82M |
| Lexeo Therapeutics, Inc.(LXEO) | 2,355,904 | 2,355,904 | 0 | $37.79M | $21.30M | 13.31% | -$16.49M |
| enGene Holdings Inc. COM | 1,076,357 | 1,076,357 | 0 | $10.15M | $7.10M | 4.44% | -$3.05M |
| Alumis Inc | 653,225 | 653,223 | -2 | $8.69M | $6.98M | 4.36% | -$1.71M |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | $3.71M | $3.89M | 2.43% | +$179.9K |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $4.61M | $3.51M | 2.19% | -$1.10M |
| Immunic, Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | $1.98M | $2.95M | 1.84% | +$965.6K |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 321,502 | 321,502 | 0 | $382.6K | $675.2K | 0.42% | +$292.6K |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | $1.30M | $540.2K | 0.34% | -$756.3K |
| Morphic Holding | 159,846 | 0 | -159,846 | $5.45M | $0 | — | -$5.45M |